Solasia Pharma K.K.

TSE:4597.T

46 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Operating Activities:
Net Income -300-310-344-334-203-247-519-740-627-606-358-701-733-650-2,231-645-746-537-176-585-537-499-896-623-601-325-585.828127.962-311.023-247.396-24.349-203.668-205.828-60.794-253.523
Depreciation & Amortization 3493122126126126145141124124124124124123124123125124127123115110100401030.1030.1030.1430.1780.1890.190.1890.3140.315
Deferred Income Tax 00000000000000000000000000000000000
Stock Based Compensation 00000000000000000000000000000000000
Change In Working Capital -2451134266-429336-1,095537116-83-209-26917-110702-79-257-302539-84194-198378-114-8-241219.349-22.835-21.674-56.442109.566-89.976-14.401-8.12724.892
Accounts Receivables -2940138340-270332-500-3693-3-7113424-36-8139-28-90148-63-27124-1341-36-5-210-15-1000000
Change In Inventory 5-20-2-3-62-41-13881-22032-30227-31111370-2653-62-34000-25.60600000
Change In Accounts Payables -20325-71-9745-58257322-78-140-403-39-44000000000000000000000
Other Working Capital 20-1-71-9863-889-81-21120-15-80700-106-226-303426-915-196313-11754-207-210-15-30.83600000
Other Non Cash Items 92136-910-478491-71-7-4191920-138599-22-3654-2324-12-565-1722-22.0860.736-12.83120.14717.9762.7916.3494.592.167
Operating Cash Flow -310-164-9768-553223-978-133-394-569-424-827-572-650-546-592-900-751544-569-204-599-474-692-616-541-388.462105.966-345.385-283.513103.382-290.663-213.691-64.017-226.149
Investing Activities:
Investments In Property Plant And Equipment 0000000-398-1-4-57-104-1-1-10-106-52-3-51-6-5-670-80-27-92-58-120.929-254.552-83.425-40.193-31.343-163.737-329.054-33.491-281.569
Acquisitions Net 00000000-1400000000000000000000000000
Purchases Of Investments 00000000-1400000000000000000000000000
Sales Maturities Of Investments 000000001400000000000000000000000000
Other Investing Activites 0000000-398-1-4-1-1031-2-21-52-1-42-5-1-691-82-36-18.316-18.232-1.6180.044-0.1520.0310.18-0.1690.056
Investing Cash Flow 000-1000-398-16-4-58-1041-3-10-105-52-4-55-4-5-671-80-26-92-58-139.245-272.784-85.043-40.149-31.495-163.706-328.874-33.66-281.513
Financing Activities:
Debt Repayment -500-5000000000-500000-1,000-1,25000000000000000000000
Common Stock Issued 443248311610101,3865846380353140910569292001,69403783,2907401.879506.9063,273.39700000
Common Stock Repurchased 000000-300000000000-22000-48000000000000
Dividends Paid 00000000000000000000000000000000000
Other Financing Activities -23-9-10-12-12-17-16-11500-11-10-12-9-112,251-11-11-33-10-11-9-493,29074-0.066-0.066-0.066-0.066-33.42-0.066-0.066-0.066-0.066
Financing Cash Flow -68743302-4-11-12-101,370573638-11343128-99-6922,543-11-111,661-10-8-2-413,29074-0.0661.813506.843,273.331-33.42-0.066-0.066-0.066-0.066
Other Information:
Effect Of Forex Changes On Cash 2110412-212181122615-8-4-3-510-2-151-54-1-20.0530.6050.025-2.838.075-0.938-7.009-4.334-1.493
Net Change In Cash -37759120867-563213-1,00983918376-490-586-436-738-1,2571,844-967-7722,160-585-233-1,272-6012,577-702-598-527.72-164.40176.4372,946.83846.541-455.373-549.641-102.078-509.22
Cash At End Of Period 9421,3197285204531,0168031,8129737907141,2041,7902,2262,9644,2212,3773,3444,1161,9562,5412,7744,0464,6472,0702,7723,370.153,897.874,062.2713,985.8341,038.996992.4551,447.8281,997.4692,099.547